Women Develop Brain Tumours After Prolonged Depo-Provera Contraceptive Use

A growing number of women are reporting the development of brain tumours after extended use of the Depo-Provera contraceptive injection. Nicola, one of the affected women, discovered she had three brain tumours following several years of receiving the jab. She subsequently connected with dozens of other women who had experienced similar diagnoses, all having used Depo-Provera over prolonged periods.

A consultant neurosurgeon, Mr. Paul Leach, has voiced concern over the cluster of cases, particularly focusing on meningioma tumours. He highlighted that while such tumours are typically linked to oestrogen, progesterone-only contraceptives like Depo-Provera warrant closer scrutiny given these reports. Mr. Leach emphasised the need for thorough investigation to ascertain any causal link.

Conversely, the Medicines and Healthcare products Regulatory Agency (MHRA), responsible for regulating medicines and medical devices in the UK, stated that its review of available data does not indicate an increased risk of brain tumours among Depo-Provera users. The MHRA advises patients to consult their doctor if they have concerns regarding their medication.

Depo-Provera is a progesterone-only contraceptive injection administered every 13 weeks. Its widespread use, particularly among younger women and those seeking alternatives to oestrogen-based contraception, underscores the importance of fully understanding any potential long-term health implications. Critics argue that regulatory bodies are often slow to acknowledge adverse effects, particularly when it challenges established medical practices.